Collagen type I在胰腺癌发展中的作用

doi:10.3969/j.issn.1009-976X.2023.03.012

摘要/Abstract

摘要： 胰腺癌（PC）是高发病率、高死亡率的恶性肿瘤,尽管目前在胰腺癌的治疗策略中已取得了较大的进展,但胰腺癌的转移、复发及高耐药性仍是大部分患者预后不良的主要原因。Ⅰ型胶原蛋白（Col-I）是人体中主要的细胞外基质蛋白,在多种实体肿瘤中表达异常并参与肿瘤的形成。最近研究表明,Col-I在胰腺癌中高度表达与胰腺癌的生长、转移、侵袭、耐药以及治疗密切相关,是胰腺癌新的潜在治疗靶点。该文重点介绍了COl-I 对胰腺癌发生发展的影响,为胰腺癌的诊断和靶向治疗提供新的思路。

关键词: Ⅰ型胶原蛋白;, 胰腺癌, 增殖, 迁移, 粘附

Abstract: Pancreatic cancer （PC）is a malignant tumor with high incidence and high mortality. Although the current treatment strategies have made great progress, metastasis, recurrence and drug resistance of pancreatic cancer are still the main reasons for poor prognosis of patients. Collagen type I （Col-I） is a major extracellular matrix protein and is abnormally expressed in a variety of solid tumors. Recent studies have shown that Col-I is highly expressed in PC, which is closely related to the growth, metastasis, invasion, drug resistance and treatment of PC, and is a new potential therapeutic target for PC. This review focuses on the effects of Col-I on the progression of PCand provides new ideas for the diagnosis and targeted therapy of PC.

Key words: collagen type I, pancreatic cancer, proliferation, migration, adhesion

中图分类号:

R817.1

康熠星, 苏延泽, 张超创, 雷德锋, 林志恒, 王荣悦, 陈霄, 刘吉奎. Collagen type I在胰腺癌发展中的作用[J]. 岭南现代临床外科, 2023, 23(03): 277-282.

KANG Yi-xing, SU Yan-ze, ZHANG Chao-chuang, LEI De-feng, LIN Zhi-heng, WANG Rong-rui, CHEN Xiao, LIU Ji-kui. The effect of collagen type Ⅰ in the progression of pancreatic cancer[J]. Lingnan Modern Clinics In Surgery, 2023, 23(03): 277-282.

参考文献

[1] 国家癌症中心, 国家肿瘤质控中心食管癌质控专家委员会. 中国食管癌规范诊疗质量控制指标(2022版)[J]. 中华肿瘤杂志, 2022, 44(12): 1242-1248.
[2] Zhao Z, Liu W.Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment[J]. Technol Cancer Res Treat, 2020, 19: 1533033820962117.
[3] Park W, ChawlAA, O'Reilly EM. Pancreatic Cancer: A Review[J]. Jama, 2021, 326(9): 851-862.
[4] Rodríguez Gil Y, Jiménez Sánchez P, Muñoz Velasco R, et al.Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic[J]. Int J Mol Sci, 2021, 22(4): 2077.
[5] Siegel RL, Miller KD, Fuchs HE, et al.Cancer Statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33.
[6] Armstrong T, Packham G, Murphy LB, et al.Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma[J]. Clin Cancer Res, 2004, 10(21): 7427-7437.
[7] Linder S, Castaños-Velez E, von Rosen A, Biberfeld P. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma[J]. Hepato-gastroenterology, 2001, 48(41): 1321-1327.
[8] Mollenhauer J, Roether I, Kern HF.Distribution of extracellular matrix proteins in pancreatic ductal adenocarcinoma and its influence on tumor cell proliferation in vitro[J]. Pancreas, 1987, 2(1): 14-24.
[9] Imamura T, Iguchi H, Manabe T, et al.Quantitative analysis of collagen and collagen subtypes I, III, and V in human pancreatic cancer, tumor-associated chronic pancreatitis, and alcoholic chronic pancreatitis[J]. Pancreas, 1995, 11(4): 357-364.
[10] Lu J, Zhou S, Siech M, et al.Pancreatic stellate cells promote hapto-migration of cancer cells through collagen I-mediated signalling pathway[J]. Br J Cancer, 2014, 110(2): 409-420.
[11] Duan W, Ma J, Ma Q, et al.The Activation of β1-integrin by Type I Collagen Coupling with the Hedgehog Pathway Promotes the Epithelial-Mesenchymal Transition in Pancreatic Cancer[J]. Curr Cancer Drug Targets, 2014, 14(5): 446-457.
[12] Shi R, Zhang Z, Zhu A, et al.Targeting type I collagen for cancer treatment[J]. Inter J Cancer, 2022, 151(5): 665-683.
[13] Chowdhury SR, Mh Busra MF, Lokanathan Y, et al.Collagen Type I: A Versatile Biomaterial[J]. Adv Exp Med Biol, 2018, 1077: 389-414.
[14] Vuorio E, de Crombrugghe B. The family of collagen genes[J]. Ann Rev Biochem, 1990, 59: 837-872.
[15] Naomi R, Ridzuan PM, Bahari H.Current Insights into Collagen Type I[J]. Polymers (Basel), 2021, 13(16): 2642.
[16] Xu R, Xia H, He W, et al.Controlled water vapor transmission rate promotes wound-healing via wound re-epithelialization and contraction enhancement[J]. Sci Rep, 2016, 6: 24596.
[17] Jain S, Tote DS, Kolte G, et al.Effect of moist dressing, collagen sheet dressing and epidermal growth factor in healing of chronic wounds[J]. Int Surg J, 2017, 4(8): 2594.
[18] Antoine EE, Vlachos PP, Rylander MN.Review of collagen I hydrogels for bioengineered tissue microenvironments: characterization of mechanics, structure, and transport[J]. Tissue Eng Part B Rev, 2014, 20(6): 683-696.
[19] Langley RR, Fidler IJ.The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs[J]. Inter J Cancer, 2011, 128(11): 2527-2535.
[20] Ribatti D, Mangialardi G, Vacca A.Stephen Paget and the ‘seed and soil’ theory of metastatic dissemination[J]. Clin Exp Med, 2006, 6(4): 145-149.
[21] Fokas E, Engenhart-Cabillic R, Daniilidis K, et al.Metastasis: the seed and soil theory gains identity[J]. Cancer Metastasis Rev, 2007, 26(3-4): 705-715.
[22] Akhtar M, Haider A, Rashid S, et al.Paget′s “Seed and Soil” Theory of Cancer Metastasis: An Idea Whose Time has Come[J]. Adv Anat Pathol, 2019, 26(1): 69-74.
[23] Lafaro KJ, Melstrom LG.The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment[J]. Am J Pathol, 2019, 189(1): 44-57.
[24] Sahai E, Astsaturov I, Cukierman E, et al.A framework for advancing our understanding of cancer-associated fibroblasts[J]. Nat Rev Cancer, 2020, 20(3): 174-186.
[25] Ishihara S, Haga H.Matrix Stiffness Contributes to Cancer Progression by Regulating Transcription Factors[J]. Cancers (Basel), 2022, 14(4): 1049.
[26] Haglund C, Roberts PJ, Nordling S, et al.Expression of laminin in pancreatic neoplasms and in chronic pancreatitis[J]. Am J Surg Pathol, 1984, 8(9): 669-676.
[27] Lee CS, Montebello J, Georgiou T, et al.Distribution of type IV collagen in pancreatic adenocarcinoma and chronic pancreatitis[J]. Inter J Exp Pathol, 1994, 75(2): 79-83.
[28] Veenstra VL, Garcia-Garijo A, Van laarhoven HW, et al. Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer[J]. Cancers (Basel), 2018, 10(2): 34.
[29] Shintani Y, Hollingsworth M A, Wheelock MJ, et al.Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH(2)-terminal kinase 1 and up-regulating N-cadherin expression[J]. Cancer Res, 2006, 66(24): 11745-11753.
[30] Erkan M, Hausmann S, Michalski CW, et al.The role of stroma in pancreatic cancer: diagnostic and therapeutic implications[J]. Nat Rev Gastroenterol Hepatol, 2012, 9(8): 454-467.
[31] Hessmann E, Buchholz SM, Demir IE, et al.Microenvironmental Determinants of Pancreatic Cancer[J]. Physiol Rev, 2020, 100(4): 1707-1751.
[32] Su H, Yang F, Fu R, et al.Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome[J]. Nature, 2022, 610(7931): 366-732.
[33] Rhim AD, Oberstein PE, Thomas DH, et al.Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma[J]. Cancer Cell, 2014, 25(6): 735-747.
[34] Chen Y, Kim J, Yang S, et al.Type I collagen deletion in alphaSMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer[J]. Cancer Cell, 2021, 39(4): 548-565 e6.
[35] Weniger M, Honselmann KC, Liss AS.The Extracellular Matrix and Pancreatic Cancer: A Complex Relationship[J]. Cancers (Basel), 2018, 10(9): 316.
[36] Olivares O, Mayers JR, Gouirand V, et al.Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions[J]. Nat Commun, 2017, 8: 16031.
[37] Huang J, Zhang L, Wan D, et al.Extracellular matrix and its therapeutic potential for cancer treatment[J]. Signal Transduct Target Ther, 2021, 6(1): 153.
[38] Socovich AM, Naba A.The cancer matrisome: From comprehensive characterization to biomarker discovery[J]. Semin Cell Dev Biol, 2019, 89: 157-166.
[39] Paszek MJ, Zahir N, Johnson KR, et al.Tensional homeostasis and the malignant phenotype[J]. Cancer Cell, 2005, 8(3): 241-254.
[40] Koenig A, Mueller C, Hasel C, et al.Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells[J]. Cancer Res, 2006, 66(9): 4662-4671.
[41] Samanta D, Almo SC.Nectin family of cell-adhesion molecules: structural and molecular aspects of function and specificity[J]. Cell Mol Life Sci, 2015, 72(4): 645-658.
[42] Li ZH, Zhou Y, Ding YX, et al.Roles of integrin in tumor development and the target inhibitors[J]. Chin J Nat Med, 2019, 17(4): 241-251.
[43] Berrier AL, Yamada KM.Cell-matrix adhesion[J]. J Cell Physiol, 2007, 213(3): 565-573.
[44] Grzesiak JJ, Bouvet M.Activation of the alpha2beta1 integrin-mediated malignant phenotype on type I collagen in pancreatic cancer cells by shifts in the concentrations of extracellular Mg²+ and Ca²+[J]. Inte J Cancer, 2008, 122(10): 2199-2209.
[45] Grzesiak JJ, Bouvet M.The alpha2beta1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines[J]. Br J Cancer, 2006, 94(9): 1311-1319.
[46] Jokinen J, Dadu E, Nykvist P, et al.Integrin-mediated cell adhesion to type I collagen fibrils[J]. J Biol Chem, 2004, 279(30): 31956-31963.
[47] Hirohashi S, Kanai Y.Cell adhesion system and human cancer morphogenesis[J]. Cancer Sci, 2003, 94(7): 575-581.
[48] Menke A, Philippi C, Vogelmann R, et al.Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines[J]. Cancer Res, 2001, 61(8): 3508-3517.
[49] Imamichi Y, Konig A, Gress T, et al.Collagen type I-induced Smad-interacting protein 1 expression downregulates E-cadherin in pancreatic cancer[J]. Oncogene, 2007, 26(16): 2381-2385.
[50] Shintani Y, Fukumoto Y, Chaika N, et al.Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1[J]. J Cell Biol, 2008, 180(6): 1277-1289.
[51] Thiery JP.Epithelial-mesenchymal transitions in tumour progression[J]. Nat Rev Cancer, 2002, 2(6): 442-454.
[52] Nakajima S, Doi R, Toyoda E, et al. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma [J]. Clin Cancer Res, 2004, 10(12 Pt 1): 4125-4133.
[53] Huang H, Svoboda RA, Lazenby AJ, et al.up-regulation of n-cadherin by collagen i-activated discoidin domain receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1[J]. J Biol Chem, 2016, 291(44): 23208-23223.
[54] Zhou P, Li B, Liu F, et al.The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer[J]. Mol Cancer, 2017, 16(1): 52.
[55] Mini E, Nobili S, Caciagli B, et al.Cellular pharmacology of gemcitabine[J]. Ann Oncol, 2006, 17(Suppl 5): v7-12.
[56] Huang P, Chubb S, Hertel LW, et al.Action of 2‘,2’-difluorodeoxycytidine on DNA synthesis[J]. Cancer Res, 1991, 51(22): 6110-6117.
[57] Burris HA, 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial[J]. J Clin Oncol, 1997, 15(6):2403-2413.
[58] Zeng S, Pöttler M, Lan B, et al.Chemoresistance in Pancreatic Cancer[J]. Int J Mol Sci, 2019, 20(18): 4504.
[59] Song Y, Kim SH, Kim KM, et al.Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids[J]. Sci Rep, 2016, 6: 36750.
[60] Netti PA, Berk DA, Swartz MA, et al.Role of extracellular matrix assembly in interstitial transport in solid tumors[J]. Cancer Res, 2000, 60(9): 2497-2503.
[61] Sun X, Cui X, Chen X, et al.Baicalein alleviated TGF β1-induced type I collagen production in lung fibroblasts via downregulation of connective tissue growth factor[J]. Biomed Pharmacother, 2020, 131: 110744.
[62] Liu P, Feng J, Sun M, et al.Synergistic effects of baicalein with gemcitabine or docetaxel on the proliferation, migration and apoptosis of pancreatic cancer cells[J]. Int J Oncol, 2017, 51(6): 1878-1886.
[63] Duarte BDP, Bonatto D.The heat shock protein 47 as a potential biomarker and a therapeutic agent in cancer research[J]. J Cancer Res Clin Oncol, 2018, 144(12): 2319-2328.
[64] Ito S, Ogawa K, Takeuchi K, et al.A small-molecule compound inhibits a collagen-specific molecular chaperone and could represent a potential remedy for fibrosis[J]. J Biol Chem, 2017, 292(49): 20076-20085.
[65] Leung L, Niculescu-Duvaz D, Smithen D, et al.Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure-Activity Relationships[J]. J Med Chem, 2019, 62(12): 5863-5884.
[66] Kim YM, Kim EC, Kim Y.The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin[J]. Mol Biol Rep, 2011, 38(1): 145-149.
[67] Wang TH, Hsia SM, Shieh TM.Lysyl Oxidase and the Tumor Microenvironment[J]. Int J Mol Sci, 2016, 18(1):62.
[68] Miller BW, Morton JP, Pinese M, et al.Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy[J]. EMBO Mol Med, 2015, 7(8): 1063-1076.
[69] Lopez NE, Prendergast C, Lowy AM.Borderline resectable pancreatic cancer: definitions and management[J]. World J Gastroenterol, 2014, 20(31): 10740-10751.